Laboratory and clinical evaluation of screening agar plates for detection of carbapenem-resistant Enterobacteriaceae from surveillance rectal swabs

Journal of Clinical Microbiology

Volumn 49, Issue 6, 2011, Pages 2239-2242

  Adler, Amos ^a   Navon Venezia, Shiri ^a   Moran Gilad, Jacob ^a   Marcos, Evgeniya ^a   Schwartz, David ^a   Carmeli, Yehuda ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; ERTAPENEM; IMIPENEM; MEROPENEM;

ACCURACY; ACINETOBACTER BAUMANNII; AGAR MEDIUM; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CHROM METHOD; CONTROLLED STUDY; ENTEROBACTERIACEAE; INTERMETHOD COMPARISON; KLEBSIELLA PNEUMONIAE; LIMIT OF DETECTION; MAC1 METHOD; MACD METHOD; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

AGAR; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; CULTURE MEDIA; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FECES; HUMANS; MASS SCREENING; MICROBIAL SENSITIVITY TESTS; SENSITIVITY AND SPECIFICITY;

ENTEROBACTERIACEAE;

EID: 79957515598     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02566-10     Document Type: Article

References (23)

1. Bilavsky, E., M. J. Schwaber, and Y. Carmeli. 2010. How to stem the tide of carbapenemase-producing enterobacteriaceae?: proactive versus reactive strategies. Curr. Opin. Infect. Dis. 23:327-331.
2. Calfee, D., and S. G. Jenkins. 2008. Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients. Infect. Control Hosp. Epidemiol. 29:966-968.
3. Chmelnitsky, I., S. Navon-Venezia, J. Strahilevitz, and Y. Carmeli. 2008. Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates. Antimicrob. Agents Chemother. 52:2962-2965.
4. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. Approved standard MS100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Goren, M. G., et al. 2010. Transfer of carbapenem-resistant plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in patients. Emerg. Infect. Dis. 16:1014-1017.
6. Goren, M. G., S. Navon-Venezia, I. Chmelnitsky, and Y. Carmeli. 2010. Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv medical center, 2005 to 2008. Antimicrob. Agents Chemother. 54:2687-2691.
7. Goren, M. G., I. Chmelnitsky, Y. Carmeli, and S. Navon-Venezia. 2011. Plasmid-encoded OXA-48 carbapenemase in Escherichia coli from Israel. J. Antimicrob. Chemother. 66:672-673.
8. Hindiyeh, M., et al. 2008. Rapid detection of blaKPC carbapenemase genes by real-time PCR. J. Clin. Microbiol. 46:2869-2873.
9. Kitchel, B., et al. 2009. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob. Agents Chemother. 53:3365-3370.
10. Landman, D., J. K. Salvani, S. Bratu, and J. Quale. 2005. Evaluation of techniques for detection of carbapenem-resistant Klebsiella pneumoniae in stool surveillance cultures. J. Clin. Microbiol. 43:5639-5641.
11. Leavitt, A., S. Navon-Venezia, I. Chmelnitsky, M. J. Schwaber, and Y. Carmeli. 2007. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob. Agents Chemother. 51:3026-3029.
12. Leavitt, A., et al. 2010. Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel. Antimicrob. Agents Chemother. 54:3002-3006.
13. Lolans, K., K. Calvert, S. Won, J. Clark, and M. K. Hayden. 2010. Direct ertapenem disk screening method for identification of KPC-producing Klebsiella pneumoniae and Escherichia coli in surveillance swab specimens. J. Clin. Microbiol. 48:836-841.
14. Marchaim, D., S. Navon-Venezia, M. J. Schwaber, and Y. Carmeli. 2008. Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes. Antimicrob. Agents Chemother. 52:1413-1418. inelevel0.
15. Navon-Venezia, S., et al. Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob. Agents Chemother. 050:3098-3101.
16. Navon-Venezia, S., et al. 2009. First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States. Antimicrob. Agents Chemother. 53:818-820.
17. Nordmann, P., G. Cuzon, and T. Naas. 2009. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis. 9:228-236.
18. Novicki, T. J., et al. 2004. Convenient selective differential broth for isolation of vancomycin-resistant enterococcus from fecal material. J. Clin. Microbiol. 42:1637-1640.
19. Poirel, L., E. Lagrutta, P. Taylor, J. Pham, and P. Nordmann. 2010. Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob. Agents Chemother. 54:4914-4916.
20. Queenan, A. M., and K. Bush. 2007. Carbapenemases: the versatile betalactamases. Clin. Microbiol. Rev. 20:440-458.
21. Samra, Z., et al. 2008. Evaluation of CHROMagar KPC for rapid detection of carbapenem-resistant Enterobacteriaceae. J. Clin. Microbiol. 46:3110-3111.
22. Schechner, V., et al. 2009. Evaluation of PCR-based testing for surveillance of KPC-producing carbapenem-resistant members of the Enterobacteriaceae family. J. Clin. Microbiol. 47:3261-3265.
23. Schwaber, M., and TASMC CRE Working Group. Abstr. 19th Annu. Sci. Meet. Soc. Healthcare Epidemiol. Am., abstr. 484.